Who qualifies

Testosterone Case Parties: Check the Product and Date

Checking which company belongs in a testosterone claim? Start with your product and dates.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202612 sources

This may apply to you if

  • Gather product names, prescriptions and dates you can confirm.
  • Keep diagnosis, treatment and authorized medical records.
  • Ask which proof, legal rules and personal time limit apply.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

U.S. Department of Health and Human Services · Publisher of the June 2026 FDA request announcement

Finding: FDA requested further revisions to age-related and prostate labeling information in June 2026. The announcement describes requested changes, not completed revisions to every product label.

HHS requested testosterone label updates (opens in a new tab) · Jun 18, 2026 · Checked Oct 4, 2026

John G. Heyburn II · United States Judicial Panel on Multidistrict Litigation · Judicial Panel on Multidistrict Litigation chair signing the cited order

Finding: The June 2014 order centralized testosterone product cases in northern Illinois before Judge Matthew F. Kennelly for pretrial proceedings. It does not establish the current stage or individual liability.

JPML initial testosterone products transfer order (opens in a new tab) · Jun 6, 2014 · Checked Oct 4, 2026

The short answer

Who may have a company claim to check?
Ask about the product used, harm and law. Keep its label and dates. A company name in an old order does not decide fault. [6]
What does not qualify as proof of company fault?
A brand headline is not a product record. A warning or study does not decide personal fault. Do not assume an old party list is today’s manufacturer list. [11]
What if I used several brands or a generic?
List each drug and date on its own. Ask the pharmacist about unclear names. A drug class does not tell you which party fits the claim. [6]
What records help identify the product and parties?
Keep pharmacy details, labels and care reports. Bring prior cases or offers. Mark unknown company names as unknown. [9]

What rules a case out

Not covered by this case

  • A study or court grouping does not decide a person’s cause, fault or payment.
  • No single national filing deadline is supplied.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

The criteria attorneys check

  1. 01

    Gather product names, prescriptions and dates you can confirm.

  2. 02

    Keep diagnosis, treatment and authorized medical records.

  3. 03

    Ask which proof, legal rules and personal time limit apply.

Checking which company belongs in a testosterone claim? Start with your product and dates. The 2014 court grouping names historical parties, not every current maker or a finding of fault.

Who may have a company claim to check?

Ask about the product used, harm and law. Keep its label and dates. A company name in an old order does not decide fault.

The June 2014 order names AbbVie and Abbott among parties to the old litigation, alongside other companies. It grouped cases for work before trial. It did not decide each company’s fault. Ask which party relates to the product and period in your own history.

What does not qualify as proof of company fault?

A brand headline is not a product record. A warning or study does not decide personal fault. Do not assume an old party list is today’s manufacturer list.

The July 2025 AndroGel label identifies ASCEND as the marketer, while the old transfer discusses a different historical company context. Marketing identification is not itself a ruling on liability. Keep those dates and roles distinct instead of applying one company name to every prescription period.

What if I used several brands or a generic?

List each drug and date on its own. Ask the pharmacist about unclear names. A drug class does not tell you which party fits the claim.

The panel considered cases involving more than one drug and different makers. That court choice did not make products or instructions interchangeable. FDA describes different forms of the medicine. Counsel should assess the actual records rather than treating the whole class as one company’s product.

What records help identify the product and parties?

Keep pharmacy details, labels and care reports. Bring prior cases or offers. Mark unknown company names as unknown.

Separate the medicine prescribed from the diagnosis and any later claim about cause. Covered health-record access has exceptions and permitted copy fees. Ask why a particular company or date appears in a legal paper; an old case number does not certify current acceptance or fault.

Is there a company-specific filing deadline?

Have a lawyer check the claim and applicable law. No national company deadline is supplied here. An old transfer date is not your filing decision.

Personal claim type and law matter to filing time. In 2014 the panel grouped pretrial work before Judge Matthew F. Kennelly, not a new filing window for every user. Bring prior cases and releases for advice about their actual effect.

What happens when I request a company claim check?

Ask which party and claim the lawyer proposes to assess. Confirm representation and written costs. A brand page does not establish an accepted case.

Read how recovery-based fees and expense deductions work, including costs without recovery. FDA’s February 2025 warning change and June 2026 requested revisions are evidence about labeling, not findings that a company owes you money. Ask what next action is needed in the actual matter.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. FDA February 2025 testosterone labeling changesFDA February 2025 testosterone labeling changes · regulator
  2. FDA current Testosterone InformationFDA current Testosterone Information · regulator
  3. HHS requested testosterone label updatesHHS requested testosterone label updates · regulator
  4. FORTESTA prescribing information and Medication Guide, July 2025FORTESTA prescribing information and Medication Guide, July 2025 · regulator
  5. Lincoff and colleagues: Cardiovascular Safety of Testosterone-Replacement TherapyLincoff and colleagues: Cardiovascular Safety of Testosterone-Replacement Therapy · study
  6. JPML initial testosterone products transfer orderJPML initial testosterone products transfer order · court
  7. Testosterone Topical: MedlinePlus Drug InformationTestosterone Topical: MedlinePlus Drug Information · regulator
  8. ABA Model Rule 1.5 feesABA Model Rule 1.5 fees
  9. HHS your medical recordsHHS your medical records · regulator
  10. SDNY how long do I have to file?SDNY how long do I have to file? · court
  11. FDA: AndroGel 1.62% July2025 label
  12. FDA: Axiron October2016 labelFDA: Axiron October2016 label · regulator

Checked against 12 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026